25 of the Best Hematologist Oncologists Near Me in Moorestown, NJ

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.

Ashish Khot, MD, is a fellowship-trained physician specializing in hematology/oncology with Atlantic Medical Group (AMG). Board-certified in hematology and medical oncology by the American Board of Internal Medicine, he has clinical expertise in diagnosing and treating blood disorders including anemia, leukemia, lymphoma and cancers of various organs, particularly lung, genitourinary, gastrointestinal and thoracic malignancies.Dr. Khot embraces a patient-centric approach, educating and empowering his patients and their families to make well-informed decisions regarding their health care. He strongly believes in fostering open communication among patients, their caregivers, and all collaborating physicians, ensuring that their care remains seamlessly coordinated throughout their challenging medical journeys.After earning his medical degree at Grant Medical College in Mumbai, India, Dr. Khot performed an internal medicine residency at St. Luke’s-Roosevelt Medical Center (now called Mt. Sinai West/Morningside) in New York City. He then received specialized training in a hematology and oncology fellowship at Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.In addition to his clinical roles, Dr. Khot is the regional medical director, eastern region at Atlantic Medical Group, overseeing multiple subspecialist clinicians and pediatric practices. He is the associate medical director for GU oncology for community oncology given his special interest in genitourinary cancer. He is a national speaker on bladder and kidney cancers. He serves on several Atlantic Health System committees, including the Overlook Medical Center Blood Bank and Transfusion Committee, as well as the Union Essex Regional Council, AMG Nomination Committee and AMG Health Equity Committee. He regularly lectures and provides teaching rotations for IM and family medicine residents and medical students at Atlantic Health System hospitals.Dr. Ashish Khot is consistently recognized as a “Top Doctor” by New Jersey Monthly magazine by his peers. He is multilingual, speaking fluent Hindi and Marathi, among other languages. Dr. Khot is a participating provider of the Atlantic Accountable Care Organization. Dr. Khot is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Anemia, Urothelial Cancer, Muscle Invasive Bladder Cancer, and Colorectal Cancer. Dr. Khot is board certified in American Board Of Internal Medicine. Dr. Khot is currently accepting new patients.

Maithili Rao, MD, is a senior health care entrepreneur board-certified in medical oncology and hematology by the American Board of Internal Medicine. She is affiliated with Advanced Care Oncology and Hematology Associates (ACOHA), part of Atlantic Medical Group (AMG). Her professional career includes building a worldclass oncology practice across six counties with 30 practitioners, serving as a medical executive board member at Overlook Hospital, and working as the enterprise medical director of Practice Growth and Integration at Atlantic Medical Group. Dr. Rao has championed an integrated approach to treating cancer and blood disorders, focusing on personalizing patient care, quality, and communication.At each oncology treatment site, Dr. Rao has successfully incorporated palliative care, genetic counseling, dietitians, navigators, social workers, onsite lab and pharmacy services, access to clinical trials, an infusion suite for chemotherapy and immunotherapy, and advanced molecular testing. These integrations enable her to deliver high-quality clinical care and innovative treatment protocols with a unique, holistic, patient-centered approach. She treats all forms of blood disease and cancer, with a special focus on breast cancer.Dr. Rao currently serves as the enterprise medical director of oncology and other specialties for Atlantic Health System (AHS), a multi-award-winning, seven-hospital, nonprofit, integrated health care network in northern New Jersey. AHS has over 400 sites of care, 300 physician practices, and 17,000 team members. Dr. Rao provides clinical and strategic direction for cancer care and has successfully transformed cancer care in New Jersey from a community-focused initiative to a leading oncology center that rivals prestigious competitors in New York City.Dr. Rao has been recognized by the American Cancer Society as a Medical Honoree and has been voted by her peers as New Jersey Monthly’s Top Doctor for over 13 years, among other accolades. Dr. Rao is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Rao is highly rated in 33 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Thrombocytopenia, Plasmacytoma, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Rao is board certified in American Board Of Internal Medicine. Dr. Rao is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Colorectal Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Anemia, Deep Vein Thrombosis, Myelodysplastic Syndrome (MDS), and Colorectal Cancer. Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Posterior Fossa Tumor. Dr. Saksena is currently accepting new patients.

Dr. Bonni Lee Guerin is a hematologist/oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center, Summit, NJ where she also serves as chair of the Breast Panel, the Multidisciplinary Breast Tumor Board and director of Oncology Education. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer.As a medical oncologist with more than 20 years of experience, Dr. Guerin is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long.Dr. Guerin earned her M.D. at SUNY Stonybrook in 1988, continued her residency at Vanderbilt University in Nashville and completed her fellowship in oncology/hematology at University of California San Diego Cancer Center. She is board certified in clinical oncology and internal medicine.Since 2002, Dr. Guerin has served as chair of the Women’s Oncology Forum, Network for Oncology Communication and Research (NOCR) – a national organization. She is a diplomate of the American Society of Clinical Oncology (ASCO) and is a recipient of the Pfizer Award for Excellence in Biochemical Research and a Member of the Expert Panel Consensus Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 10 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, and was the keynote speaker at the American Cancer Society Relay for Life in Chatham, NJ. Her interests are in breast cancer, hepatobiliary cancer and immunotherapy. Dr. Guerin is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Guerin is board certified in American Board Of Internal Medicine. Dr. Guerin is currently accepting new patients.

Madhurima Anne is a Hematologist Oncology provider practicing medicine in Neptune, New Jersey. Dr. Anne is highly rated in 45 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Anne is board certified in American Board Of Internal Medicine and Internal Medicine. Dr. Anne is currently accepting new patients.

Matthew Matasar is a Hematologist and an Oncologist practicing medicine in New Brunswick, New Jersey. Dr. Matasar is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Matasar is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Farber is board certified in American Board Of Internal Medicine. Dr. Farber is currently accepting new patients.

Aziz Nazha is a Hematologist and a Hematologist Oncology provider practicing medicine in Sewell, New Jersey. Dr. Nazha is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nazha is board certified in Hematology/Oncology and Medical Oncology. Dr. Nazha is currently accepting new patients.

Christina Chu is an Oncologist and a Hematologist Oncology provider practicing medicine in Camden, New Jersey. Dr. Chu is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor. Dr. Chu is board certified in American Board Of Obstetrics And Gynecology,Gynecologic Oncology , 2006 and American Board Of Obstetrics And Gynecology,Obstetrics And Gynecology , 2004.

Dr. Emmanuel Apor's desire to take care of people channeled him into the field of medicine - specifically into cancer care. Board certified in internal medicine with fellowship training in hematology-oncology, Dr. Apor strives to first understand who his patients are as people, then learn about their disease.While attaining his bachelors of art degree at Rutgers University, Dr. Apor worked at a local hospital which cemented his decision to pursue postgraduate training. He achieved his medical degree at Drexel University College of Medicine in Philadelphia and his residency at the Warren Alpert Medical School at Brown University, where he developed a passion for clinical care working with his general internist mentors and their patients.Dr. Apor attained his fellowship training in hematology-oncology at Brown University, where he served in teaching and research roles, and he held hospital appointments at both Providence Veterans Affairs Medical Center and Rhode Island Hospital. Dr. Apor is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Thrombocytopenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Apor is board certified in American Board Of Internal Medicine. Dr. Apor is currently accepting new patients.

Tatyana Feldman is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Feldman is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Feldman is board certified in Hematology and American Board Of Internal Medicine . Dr. Feldman is currently accepting new patients.

Michele Donato is an Oncologist and a Hematologist practicing medicine in Neptune, New Jersey. Dr. Donato is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy. Dr. Donato is board certified in American Board Of Internal Medicine. Dr. Donato is currently accepting new patients.

Jamie Koprivnikar is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Koprivnikar is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Endoscopy. Dr. Koprivnikar is board certified in American Board Of Internal Medicine. Dr. Koprivnikar is currently accepting new patients.

Lori Leslie is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. She has been practicing medicine for over 17 years. Dr. Leslie is highly rated in 35 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Leslie is currently accepting new patients.

Andre Goy is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Goy is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Tissue Biopsy. Dr. Goy is currently accepting new patients.

Loren Michel is a Hematologist and an Oncologist practicing medicine in Basking Ridge, New Jersey. Dr. Michel is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Adenoid Cystic Carcinoma, Polymorphous Low Grade Adenocarcinoma, and Epithelial-Myoepithelial Carcinoma. Dr. Michel is board certified in American Board Of Internal Medicine. Dr. Michel is currently accepting new patients.

Noa Biran is an Oncologist and a Hematologist practicing medicine in Edison, New Jersey. Dr. Biran is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Plasmacytoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Biran is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Biran is currently accepting new patients.

Harsh Parmar is an Oncologist and a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Parmar is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Parmar is board certified in American Board Of Internal Medicine , American Board Of Internal Medicine , and American Board Of Internal Medicine. Dr. Parmar is currently accepting new patients.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is highly rated in 50 conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Morganstein is board certified in American Board Of Internal Medicine. Dr. Morganstein is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is highly rated in 44 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration. Dr. Cherry is board certified in American Board Of Internal Medicine. Dr. Cherry is currently accepting new patients.

Noah Lindenberg is a Hematologist and a Hematologist Oncology provider practicing medicine in Marlton, New Jersey. Dr. Lindenberg is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Lung Cancer, and Ovarian Carcinosarcoma. Dr. Lindenberg is board certified in Oncology and Hematology. Dr. Lindenberg is currently accepting new patients.